Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Neal L. Benowitz, MD
|
|
Give Review
Neal Benowitz practices Internal Medicine. He went to medical school at Albert Einstein College of Medicine at Jacobi Medical Center. He has 1 awards "Elected Member". Doctor Neal L. Benowitz, MD is also published. He has 101 publications published. The lastest publication: "Minoxidil-Associated Pleuropericardial Effusion.' Neal Benowitz accepts Medicare.
Publications
- Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes.
- Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.
- Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels.
- Compensatory smoking from gradual and immediate reduction in cigarette nicotine content.
- Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers.
- Multiple risk-behavior profiles of smokers with serious mental illness and motivation for change.
- Intake of Toxic and Carcinogenic Volatile Organic Compounds from Secondhand Smoke in Motor Vehicles.
- Secondhand Tobacco Smoke Exposure Among Hospitalized Nonsmokers With Coronary Heart Disease.
- Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
- A comparison of nicotine biomarkers and smoking patterns in daily and nondaily smokers.
- Prevalence and Impact of Active and Passive Cigarette Smoking in Acute Respiratory Distress Syndrome.
- Reduced nicotine product standards for combustible tobacco: Building an empirical basis for effective regulation.
- Nicotine and Carcinogen Exposure after Water Pipe Smoking in Hookah Bars.
- Electronic cigarettes.
- E-cigarettes: a scientific review.
- Emerging nicotine delivery products. Implications for public health.
- Factors associated with discontinuation of bupropion and counseling among african american light smokers in a randomized clinical trial.
- Cotinine and Tobacco-Specific Carcinogen Exposure Among Nondaily Smokers in a Multiethnic Sample.
- Clinical Significance of Early Smoking Withdrawal Effects and Their Relationships With Nicotine Metabolism: Preliminary Results From a Pilot Study.
- Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke.
- Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.
- Influence of a Dopamine Pathway Additive Genetic Efficacy Score on Smoking Cessation: Results from Two Randomized Clinical Trials of Bupropion.
- Validity of self-reported adult secondhand smoke exposure.
- Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non- Smokers.
- The Regulatory Challenge of Electronic Cigarettes.
- The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence.
- Comparison of nicotine and carcinogen exposure with water pipe and cigarette smoking.
- Stability of the Nicotine Metabolite Ratio in Smokers of Progressively Reduced Nicotine Content Cigarettes.
- Reducing the nicotine content to make cigarettes less addictive.
- Assessing secondhand smoke using biological markers.
- CYP2A6 Genotype but not Age Determines Cotinine Half-life in Infants and Children.
- Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.
- Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.
- Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure.
- Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state.
- Tobacco use among southwestern alaska native people.
- Smoking cessation after acute myocardial infarction.
- Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
- High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine: A Proof of Concept Placebo-Controlled Trial.
- Biomarkers of secondhand smoke exposure in automobiles.
- Race, Gender, and Nicotine Metabolism in Adolescent Smokers.
- Very low nicotine content cigarettes and potential consequences on cardiovascular disease.
- Gender-stratified gene and gene-treatment interactions in smoking cessation.
- Particulate mass and polycyclic aromatic hydrocarbons exposure from secondhand smoke in the back seat of a vehicle.
- Nicotine intake and smoking topography in smokers with bipolar disorder.
- Nicotine Metabolism and Addiction among Adolescent Smokers.
- Exposure to Nicotine and Carcinogens among Southwestern Alaskan Native Cigarette Smokers and Smokeless Tobacco Users.
- The exposure-dependent effects of aged secondhand smoke on endothelial function.
- Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers.
- Response to "The Role of Cannabinoids in Chronic Pain Patients Remains Hazy"
- Exposure and Kinetics of Polycyclic Aromatic Hydrocarbons (PAHs) in Cigarette Smokers.
- DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.
- Chronic disease management approach to treating tobacco addiction: comment on "nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit".
- Gene-Centric Analysis of Serum Cotinine Levels in African and European American Populations.
- Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials.
- Cardiology Rx for Change: Improving Clinical Attention to Tobacco Use and Secondhand Smoke Exposure in Cardiology.
- Nicotine, carbon monoxide, and carcinogen exposure after a single use of a water pipe.
- Sodium oxybate: updates and correction to previously published safety data.
- The threat of menthol cigarettes to U.S. public health.
- Effect of nicotine on cytochrome P450 1A2 activity.
- Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.
- Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.
- Genetic variability of smoking persistence in african americans.
- Do biological differences help explain tobacco-related disparities?
- Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
- Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Inc...
- Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.
- Urine menthol as a biomarker of mentholated cigarette smoking.
- Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
- Nicotine deprivation and pilot performance during simulated flight.
- Nicotine addiction.
- Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.
- Varenicline and pheochromocytoma.
- Secondhand smoke and infectious disease in adults: A global women's health concern: Comment on "Passive Smoking and Tuberculosis".
- Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
- Chinese "herbal" cigarettes are as carcinogenic and addictive as regular cigarettes.
- Utility and relationships of biomarkers of smoking in African-American light smokers.
- Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
- Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening.
- Dopamine genes and nicotine dependence in treatment-seeking and community smokers.
- Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.
- Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
- Progressive commercial cigarette yield reduction: biochemical exposure and behavioral assessment.
- Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004.
- Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
- Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chroma...
- Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers.
- A randomized trial of nicotine nasal spray in adolescent smokers.
- Nicotine and postoperative management of pain.
- Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.
- Chocolate consumption in pregnancy and reduced likelihood of preeclampsia.
- Neurobiology of nicotine addiction: implications for smoking cessation treatment.
- Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?
- Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
- Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.
- Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation.
- CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.
- Cigarette smoking and the personalization of irinotecan therapy.
- Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.
- Minoxidil-Associated Pleuropericardial Effusion.
Schools
University Of Rochester
Bronx Muni Hospital Center
Uc San Francisco
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
UCSF -
Albert Einstein College of Medicine at Jacobi Medical Center -
University of Rochester School of Medicine and Dentistry
Hospital
-
UCSF Medical Center -
John Muir Medical Center, Walnut Creek -
San Francisco General Hospital and Trauma Center -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1538103411 | |
| NPPES Provider LastName | BENOWITZ | |
| NPPES Provider FirstName | NEAL | |
| NPPES Provider ZIPCode | 941103518 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 347.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538103411 |
| Last Name Of The Provider | BENOWITZ |
| First Name Of The Provider | NEAL |
| View All |
Similar Doctors
|
Dr. James Hansen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molly Cooke, MD |
|
|
Dr. Davy Wu, MD |
|
|
Dr. Gina L. Gregory, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adriana Izquierdo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher T. Sha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franciscus M. Delen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sahael M. Stapleton, MD
This Doctor is OpenDoctor Recommended.
|